Back to Search
Start Over
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
- Source :
-
Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2019 Oct 01; Vol. 26 (10), pp. 879-889. Date of Electronic Publication: 2019 Mar 06. - Publication Year :
- 2019
-
Abstract
- Aim: Advanced glycation end-products (AGEs) have been involved in the atherogenic process in the high-risk population. The goal of this study was to demonstrate that AGEs are related to subclinical atheromatous disease in subjects with low to moderate vascular risk.<br />Methods: A cross-sectional study in which 2,568 non-diabetic subjects of both sexes without cardiovascular disease were included. Subcutaneous content of AGEs was assessed by skin autofluorescence (SAF) and subclinical atheromatous disease was measured by assessing the atheromatous plaque burden in carotid and femoral regions using ultrasonography. In addition, serum pentosidine, carboxymethyl-lysine (CML) and AGE receptors (RAGE) were assessed in a nested case-control study with 41 subjects without plaque and 41 individuals subjects with generalized disease.<br />Results: Patients with atheromatous plaque had a higher SAF than those with no plaque (1.9 [1.7 to 2.3] vs. 1.8 [1.6 to 2.1] arbitrary units (AU), p<0.001). The SAF correlated with the total number of affected regions (r= 0.171, p<0.001), increasing progressively from 1.8 [1.6 to 2.1] AU in those without atheromatous disease to 2.3 [1.9 to 2.7] AU in patients with ≥ 8 plaques (p<0.001). A correlation was also observed between SAF and the total plaque area (r=0.113, p<0.001). The area under the Receiver Operating Characteristic curve was 0.65 (0.61 to 0.68) for identifying male subjects with atheromatous disease. The multivariable logistic regression model showed a significant and independent association between SAF and the presence of atheromatous disease. However, no significant differences in serum pentosidine, CML, and RAGE were observed.<br />Conclusions: Increased subcutaneous content of AGEs is associated with augmented atheromatous plaque burden. Our results suggest that SAF may provide clinically relevant information to the current strategies for the evaluation of cardiovascular risk, especially among the male population.
- Subjects :
- Arginine metabolism
Case-Control Studies
Cross-Sectional Studies
Female
Fluorescence
Follow-Up Studies
Humans
Lysine metabolism
Male
Middle Aged
Optical Imaging
Plaque, Atherosclerotic metabolism
Prognosis
Prospective Studies
ROC Curve
Arginine analogs & derivatives
Glycation End Products, Advanced metabolism
Lysine analogs & derivatives
Plaque, Atherosclerotic diagnosis
Skin metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1880-3873
- Volume :
- 26
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Journal of atherosclerosis and thrombosis
- Publication Type :
- Academic Journal
- Accession number :
- 30842389
- Full Text :
- https://doi.org/10.5551/jat.47498